Toward a Comprehensive Model of ∆9-Tetrahydrocannabinol Pharmacokinetics Using a Population Pharmacokinetics Approach Brett C. Ginsburg Commentary 07 November 2014 Pages: 129 - 131
Clinical and Preclinical Pharmacokinetics and Pharmacodynamics of Mipomersen (Kynamro®): A Second-Generation Antisense Oligonucleotide Inhibitor of Apolipoprotein B Richard S. GearyBrenda F. BakerStanley T. Crooke Review Article Open access 06 January 2015 Pages: 133 - 146
Clinical Pharmacokinetics and Pharmacodynamics of Clopidogrel Xi-Ling JiangSnehal SamantStephan Schmidt Review Article 06 January 2015 Pages: 147 - 166
Tramadol and O-Desmethyl Tramadol Clearance Maturation and Disposition in Humans: A Pooled Pharmacokinetic Study Karel AllegaertNick HolfordUlrike Stamer Original Research Article 26 September 2014 Pages: 167 - 178
Prediction of Drug Disposition in Diabetic Patients by Means of a Physiologically Based Pharmacokinetic Model Jia LiHai-fang GuoXiao-dong Liu Original Research Article 15 October 2014 Pages: 179 - 193
A Prospective Population Pharmacokinetic Analysis of Sapropterin Dihydrochloride in Infants and Young Children with Phenylketonuria Yulan QiDiane R. MouldDonald G. Musson Original Research Article Open access 23 October 2014 Pages: 195 - 207
Population Pharmacokinetic Model of THC Integrates Oral, Intravenous, and Pulmonary Dosing and Characterizes Short- and Long-term Pharmacokinetics Jules A. A. C. HeubergerZheng GuanJan Freijer Original Research Article 15 October 2014 Pages: 209 - 219